Mirion reported FY 2025 revenue of USD 925.4 million (+7.5%), with Nuclear & Safety revenue of USD 614.6 million and Medical revenue of USD 310.8 million. FY 2025 net income was USD 29.8 million, compared with a net loss in FY 2024, while income from operations was USD 51.5 million (FY 2024: USD 24.8 million). FY 2025 interest expense, net was USD 30.1 million, and Mirion recorded a FY 2025 loss on debt extinguishment of USD 5.8 million related to its June 2025 term-loan refinancing. FY 2025 adjusted EBITDA was USD 227.9 million. Mirion ended FY 2025 with USD 412.3 million in cash and cash equivalents and said remaining performance obligations were USD 1,104.3 million as of December 31, 2025. Corporate updates during 2025 included the acquisition of Certrec (closed July 31, 2025; purchase consideration USD 82.9 million) and the acquisition of Paragon Energy Solutions (closed December 1, 2025; gross purchase consideration USD 588.4 million). Mirion also completed a USD 400.0 million 0.25% convertible notes offering due 2030 in May 2025 and a USD 375.0 million 0.00% convertible notes offering due 2031 in September 2025, alongside a September 2025 public offering of 19,906,322 Class A shares at USD 21.35 per share.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirion Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-009869), on February 19, 2026, and is solely responsible for the information contained therein.
Comments